M C Herwig-Carl1,2, K U Loeffler3,4, I Schulze5, F G Holz3, G Geerling6. 1. Klinik für Augenheilkunde, Universitätsklinikum Bonn, Venusberg-Campus 1, Gebäude 04/05, 53127, Bonn, Deutschland. martina.herwig-carl@ukbonn.de. 2. Ophthalmopathologisches Labor, Klinik für Augenheilkunde, Universitätsklinikum Bonn, Bonn, Deutschland. martina.herwig-carl@ukbonn.de. 3. Klinik für Augenheilkunde, Universitätsklinikum Bonn, Venusberg-Campus 1, Gebäude 04/05, 53127, Bonn, Deutschland. 4. Ophthalmopathologisches Labor, Klinik für Augenheilkunde, Universitätsklinikum Bonn, Bonn, Deutschland. 5. Apotheke, Universitätsklinikum Bonn, Bonn, Deutschland. 6. Klinik für Augenheilkunde, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland.
Abstract
BACKGROUND: Bottlenecks in drug supply in the field of ophthalmological are continuously increasing in Germany. So far, these have hardly been communicated and discussed. We see the transparent presentation of the problem as a first step in compiling concepts to counteract this development. AIM OF THE WORK: Presentation of the supply shortages in ophthalmological drugs. MATERIAL AND METHODS: A listing and discussion of the shortages in drug supply to the best of our knowledge are presented. RESULTS: We distinguish between the problems in (1) supply shortages, (2) discontinuation of production, (3) lack of availability in Germany and (4) manufacture of drugs in specialized pharmacies often lacking approval for the ophthalmological indications. DISCUSSION: The reasons for drug supply shortages in ophthalmology are complex and therefore no easy solutions can be expected; however, industrial and regulatory authorities at the national and European levels are called upon to analyze the underlying problems and to find appropriate solutions.
BACKGROUND: Bottlenecks in drug supply in the field of ophthalmological are continuously increasing in Germany. So far, these have hardly been communicated and discussed. We see the transparent presentation of the problem as a first step in compiling concepts to counteract this development. AIM OF THE WORK: Presentation of the supply shortages in ophthalmological drugs. MATERIAL AND METHODS: A listing and discussion of the shortages in drug supply to the best of our knowledge are presented. RESULTS: We distinguish between the problems in (1) supply shortages, (2) discontinuation of production, (3) lack of availability in Germany and (4) manufacture of drugs in specialized pharmacies often lacking approval for the ophthalmological indications. DISCUSSION: The reasons for drug supply shortages in ophthalmology are complex and therefore no easy solutions can be expected; however, industrial and regulatory authorities at the national and European levels are called upon to analyze the underlying problems and to find appropriate solutions.
Authors: Camiel J F Boon; Reinier O Schlingemann; Marc J Sirks; Elon H C van Dijk; Noa Rosenberg; Carla E M Hollak; Stamatios Aslanis; Chui Ming Gemmy Cheung; Itay Chowers; Chiara M Eandi; K Bailey Freund; Frank G Holz; Peter K Kaiser; Andrew J Lotery; Kyoko Ohno-Matsui; Giuseppe Querques; Yousif Subhi; Ramin Tadayoni; Charles C Wykoff; Dinah Zur; Roselie M H Diederen Journal: Acta Ophthalmol Date: 2022-04-06 Impact factor: 3.988
Authors: Harminder S Dua; Dalia G Said; Elisabeth M Messmer; Maurizio Rolando; Jose M Benitez-Del-Castillo; Parwez N Hossain; Alex J Shortt; Gerd Geerling; Mario Nubile; Francisco C Figueiredo; Saaeha Rauz; Leonardo Mastropasqua; Paolo Rama; Christophe Baudouin Journal: Prog Retin Eye Res Date: 2018-04-23 Impact factor: 21.198
Authors: Carol L Shields; Swathi Kaliki; H Jane Kim; Saad Al-Dahmash; Sanket U Shah; Sara E Lally; Jerry A Shields Journal: Cornea Date: 2013-03 Impact factor: 2.651
Authors: Carol L Shields; Alexandru B Constantinescu; Sefy A Paulose; Antonio Yaghy; Lauren A Dalvin; Jerry A Shields; Sara E Lally Journal: Indian J Ophthalmol Date: 2021-03 Impact factor: 1.848